Search for novel biomarkers for predicting perinatal outcomes in pregnancy complicated by gestational diabetes
Open Access
- 23 January 2026
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (11) , 4454
Abstract
Aim. To identify new markers using omics technologies for use as predictors of fetal growth and developmental abnormalities in gestational diabetes (GD). Material and methods . The long-term goal of this study is to create a unique biological sample collection that can be used to assess the risk of diabetic fetopathy (DF) and other adverse perinatal outcomes by identifying early preclinical markers. To achieve this goal, the following studies were planned for the first stage: the formation of a reference collection of biomaterial from women with a known perinatal outcome and its subsequent comprehensive analysis to identify key markers. Conducting complex experiments using genetic, immunological, and mass spectrometric approaches allows for a comprehensive assessment of molecular GD pathogenesis and the identification of complementary biomarkers. For this study, a collection of plasma samples from pregnant women in the first trimester, women in labor, amniotic fluid, and umbilical cord plasma was compiled. The resulting biomaterial samples were frozen and stored at a temperature not exceeding -80 оC. A sample of 100 women aged 18-45 years, at 34 weeks 1 day to 41 weeks 6 days of gestation, from both groups with and without GD, was included in the current study. Enzyme-linked immunosorbent assay (ELISA) was performed on samples for a number of regulatory proteins and embryotropic antibodies, molecular genetic analysis of hemostasis gene polymorphisms, and mass spectrometric analysis of amino acids. Results . A comparative analysis revealed that pregnant women with GD were more likely to have the FGB 455 G/A fibrinogen gene polymorphism (p=0,008), and their autoimmune antibody profile was altered, consistent with supraphysiological apoptosis and insulin resistance. In the absence of fetal macrosomia, maternal plasma levels of tissue plasminogen activator were lower (p=0,001). The main findings of mass spectrometry of amino acids in the blood of women with GD were lower concentrations of tryptophan (p=0,025) and γ-aminobutyric acid (p=0,023). In amniotic fluid and cord blood in GD, decreased concentrations of amino acids responsible for protein synthesis (lysine and methionine) and increased concentrations of amino acids associated with macrosomia were detected. Conclusion . The study results confirm metabolic, immune, and hemorheological disturbances in maternal GD, associated with abnormal amino acid composition in cord blood and amniotic fluid in neonates with macrosomia. The identified differences in the metabolome can be considered potential markers for identifying the risk of unfavorable perinatal outcomes.Keywords
This publication has 30 references indexed in Scilit:
- Maternal and cord serum levels of sFlt-1 and PlGF in pregnancies complicated by gestational diabetes mellitus: a prospective cohort studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2025
- Overexpression of the LAT1 in primary human trophoblast cells increases the uptake of essential amino acids and activates mTOR signalingClinical Science, 2023
- STZ-induced gestational diabetes exposure alters PTEN/AKT/mTOR-mediated autophagy signaling pathway leading to increase the risk of neonatal hypoxic-ischemic encephalopathyReproductive Toxicology, 2023
- Abnormal tryptophan catabolism in diabetes mellitus and its complications: Opportunities and challengesBiomedicine & Pharmacotherapy, 2023
- Associations between Human Chorionic Gonadotropin, Maternal Free Thyroxine, and Gestational Diabetes MellitusThyroid®, 2021
- Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitusScientific Reports, 2021
- Kisspeptins and Glucose Homeostasis in Pregnancy: Implications for Gestational Diabetes Mellitus—a Review ArticleReproductive Sciences, 2021
- Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentationHuman Reproduction Update, 2018
- Plasticity of GABAA Receptors during Pregnancy and Postpartum Period: From Gene to FunctionNeural Plasticity, 2015
- Plasma Amino Acid Levels and Insulin Secretion in ObesityNew England Journal of Medicine, 1969